FDA Issues a GRAS No Objections Letter for GenoFocus' Lactase
페이지 정보
작성자 관리자 작성일22-01-24 11:36 조회2,330회 댓글0건관련링크
본문
FDA Issues a GRAS No Objections Letter for GenoFocus' Lactase
GenoFocus is pleased to announce that the FDA has issued a GRAS no objections letter for GenoFocus' Lactase, demonstrating our enzyme's safety.
